High triglyceride causes: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Robot: Changing Category:Up-To-Date Cardiology to Category:Up-To-Date cardiology)
Line 56: Line 56:
[[fr:Hypertriglycéridémie]]
[[fr:Hypertriglycéridémie]]
[[pt:Hipertrigliceridemia]]
[[pt:Hipertrigliceridemia]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}


[[Category:Cardiology]]
[[Category:Cardiology]]
Line 65: Line 67:
[[Category:Lipid disorders]]
[[Category:Lipid disorders]]
[[Category:Medical conditions related to obesity]]
[[Category:Medical conditions related to obesity]]
[[Category: Up-To-Date]]
[[Category:Up-To-Date]]
[[Category: Up-To-Date Cardiology]]
[[Category:Up-To-Date cardiology]]
 
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Revision as of 20:48, 22 November 2011

Template:Hypertriglyceridemia

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]

Overview

Hypertriglyceridemia can occur due to various causes, including genetics, familial, metabolic and drugs

Causes

Primary hypertriglyceridemia

Genetics [1]

Type I hyperlipoproteinemia
  • Genetic deficiency or dysfunction of enzyme lipoprotein lipase (LPL)
  • Deficiency of apo C-II, that acts as a cofactor of LPL
  • Insulin deficiency or dysfunction in diabetes type 1 and 2 can also cause this disorder as LPL requires insulin for its full function.
Familial combined hyperlipidemia
  • Autosomal dominant disorder
  • Patients have either isolated triglyceride or LDL-c elevations or both.
  • Family history of premature coronary artery disease in 1 or more first-degree relatives
  • Family history for elevated triglycerides with or without elevated LDL-c levels.
Familial hypertriglyceridemia
  • Autosomal dominant trait
  • These patients and their families have isolated triglyceride elevations
  • Increased risk of premature coronary artery disease.

Idiopathic (constitutional)

Secondary hypertriglyceridemia

Metabolic [1]

Drugs

Miscellaneous

References

  1. 1.0 1.1 Kolovou GD, Anagnostopoulou KK, Kostakou PM, Bilianou H, Mikhailidis DP (2009). "Primary and secondary hypertriglyceridaemia". Curr Drug Targets. 10 (4): 336–43. PMID 19355858.

Template:WikiDoc Sources